STARHEALTH Star Health and Allied Insurance Company Q3 FY26 results (Oct–Dec 2025) and concall
Star Health delivered a robust Q3 FY26 performance characterized by strong top-line growth and significant margin expansion. The company successfully transitioned to an IND AS reporting framework, showcasing an underwriting profit of ₹46 crore for the quarter. Management highlighted a structural shift towards retail and long-term policies, alongside aggressive digital transformation and improved loss ratios across both fresh and renewal books.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 10.1%, net profit down 40.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 4,058 | 4,146 | 4,081 | 4,880 | 4,378 +8% | 4,566 +10% |
| EBITDA | 147 | 285 | -7 | 588 | 75 −49% | 172 −40% |
| Net profit | 111 | 215 | 1 | 438 | 55 −50% | 128 −40% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
